Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press11010.17650/1726-9776-2011-7-1-85-89DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCERДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыряPERCUTANEOUS ENDOSCOPIC ELECTRORESECTION OF RENAL PELVIC TUMORSЧРЕСКОЖНАЯ ЭНДОСКОПИЧЕСКАЯ ЭЛЕКТРОРЕЗЕКЦИЯ ОПУХОЛЕЙ ЛОХАНКИKomyakovB. K.КомяковБ. К.
Russian Federation
gulievbg@mail.ruGulievB. G.ГулиевБ. Г.
Russian Federation
gulievbg@mail.ruMakovskiyA. I.МаковскаяА. И.
Russian Federation
gulievbg@mail.ruKimV. E.КимВ. Е.
Russian Federation
gulievbg@mail.ruIdrisovSh. N.ИдрисовШ. Н.
Russian Federation
gulievbg@mail.ruDepartment of Urology, I.I. Mechnikov Saint Petersburg State Medical AcademyКафедра урологии Санкт-Петербургской государственной медицинской академии им. И.И. Мечникова300320117185892707201427072014https://oncourology.abvpress.ru/oncur/article/view/110

The paper gives the results of percutaneous electroresection of the renal pelvic wall with a tumor in 4 patients. The operation has been made for absolute indications: 3 patients had a single kidney and the fourth patient had a single functioning left kidney (the right pelvic dystopic kidney failed to function). In all the patients, the primary symptom of the disease was macrohematuria, the examination for which revealed a renal pelvic tumor measuring 1.2 to 2.5 cm in size. There were no complications after percutaneous electroresection of the renal pelvic wall with a tumor. Intrarenal BCG therapy was performed in the postoperative period. Percutaneous electroresection is indicated for tumors of the renal pelvis and the upper third of the ureter of the single kidney.

В статье приведены результаты чрескожной электрорезекции стенки лоханки с опухолью, выполненной у 4 пациентов. Операция была проведена по абсолютным показаниям: трое больных имели единственную почку, а четвертый – единственно функционирующую левую почку (правая тазоводистопированная почка не функционировала). Первичным симптомом заболевания у всех пациентов являлось наличие макрогематурии, при обследовании по поводу которой была выявлена опухоль лоханки размерами от 1,2 до 2,5 см. Осложнений после осуществления перкутанной электрорезекции стенки лоханки с опухолью не наблюдали. В послеоперационном периоде проведена интраренальная БЦЖ-терапия. При опухолях лоханки и верхней трети мочеточника единственной почки показана их перкутанная электрорезекция.

upper urinary tractrenal pelvistumorpercutaneous endoscopic electroresectionверхние мочевыводящие путипочечная лоханкаопухольчрескожная эндоскопическая электрорезекция1. Hall M.C., Womack S., Sagalowsky A.I. et al. Prognostic factors, recurrence and survival in transitional cell carcinoma of upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594–601.Hall M.C., Womack S., Sagalowsky A.I. et al. Prognostic factors, recurrence and survival in transitional cell carcinoma of upper urinary tract: a 30-year experience in 252 patients. Urology 1998;52:594–601.2. Jemal A., Siegel R., Ward E., Murray T. et al. Cancer statistics, 2007. Cancer J Clin 2007;57:43–66.Jemal A., Siegel R., Ward E., Murray T. et al. Cancer statistics, 2007. Cancer J Clin 2007;57:43–66.3. Комяков Б.К., Идрисов Ш.Н., Новиков А.И. и др. Оперативное лечение эпителиальных опухолей верхних мочевыводящих путей. Урология 2004;4:12–6.Комяков Б.К., Идрисов Ш.Н., Новиков А.И. и др. Оперативное лечение эпителиальных опухолей верхних мочевыводящих путей. Урология 2004;4:12–6.4. Oosterlink W., Solsona E., Van der Meijden A.P. et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004;46:147–54.Oosterlink W., Solsona E., Van der Meijden A.P. et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004;46:147–54.5. Argyropoulos A.N., Tolley D.A. Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approach. BJU Int 2007;99:982–7.Argyropoulos A.N., Tolley D.A. Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approach. BJU Int 2007;99:982–7.6. Zigeuner R., Pummer K. Urothelial carcinoma of the upper urinary tract: Surgical approach and prognostic factors. Eur Urol 2008;53:720–31.Zigeuner R., Pummer K. Urothelial carcinoma of the upper urinary tract: Surgical approach and prognostic factors. Eur Urol 2008;53:720–31.7. Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001;36:46–51.Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001;36:46–51.8. Shalhav A.L., Portis A.J., Mc Dougall E.M. et al. Laparoscopic nephroureterectomy. A new standard for the surgical management of upper tract transitional cell cancer. Urol Clin North Am 2000;27:761–73.Shalhav A.L., Portis A.J., Mc Dougall E.M. et al. Laparoscopic nephroureterectomy. A new standard for the surgical management of upper tract transitional cell cancer. Urol Clin North Am 2000;27:761–73.9. Simone G., Papalia R., Guaglianone S., Ferriero M. et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomized prospective study. Eur Urol 2009;56:520–6.Simone G., Papalia R., Guaglianone S., Ferriero M. et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomized prospective study. Eur Urol 2009;56:520–6.10. Roupret M., Traxer O., Tligui M. et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 2007;51:709–14.Roupret M., Traxer O., Tligui M. et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 2007;51:709–14.11. Irwin B.H., Berger A.K., Brandina R. et al. Complex percutaneous resections of upper tract urothelial carcinoma. J Endourol 2010;24:367–70.Irwin B.H., Berger A.K., Brandina R. et al. Complex percutaneous resections of upper tract urothelial carcinoma. J Endourol 2010;24:367–70.12. Elliott D.S., Segura J.W., Lighter D. et al. Is nephoureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001;58:174–8.Elliott D.S., Segura J.W., Lighter D. et al. Is nephoureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001;58:174–8.13. Goel M.C., Mahendra V., Roperts J.G. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol 2003;169:925–9.Goel M.C., Mahendra V., Roperts J.G. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol 2003;169:925–9.14. Soderdahl D.W., Fabrizio M.D., Rahman N.U. et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005;23:114–22.Soderdahl D.W., Fabrizio M.D., Rahman N.U. et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005;23:114–22.15. Clark P.E., Streem S.B., Geisinger M.A. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 1999;161:772–6.Clark P.E., Streem S.B., Geisinger M.A. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 1999;161:772–6.16. Rastinehad A.R., Ost M.C., VanderBrink B.A. et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: Is there an oncologic benefit with adjuvant bacillus Calmette-Guerin therapy? Urology 2009;73:27–31.Rastinehad A.R., Ost M.C., VanderBrink B.A. et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: Is there an oncologic benefit with adjuvant bacillus Calmette-Guerin therapy? Urology 2009;73:27–31.17. Yamada Y., Kobayashi Y., Yao A. et al. Nephrostomy tract tumor sedding following percutaneous manipulation of a renal pelvic carcinoma. Acta Urol Japan 2002;48:415–8.Yamada Y., Kobayashi Y., Yao A. et al. Nephrostomy tract tumor sedding following percutaneous manipulation of a renal pelvic carcinoma. Acta Urol Japan 2002;48:415–8.18. Schenberg M.P., Van Arsdalen K.N., Wein A.J. The management of transitional cell carcinoma in solitary renal units. J Urol 1991;146:700–3.Schenberg M.P., Van Arsdalen K.N., Wein A.J. The management of transitional cell carcinoma in solitary renal units. J Urol 1991;146:700–3.19. Plancke H.R., Strijbos W.E., Delaere K.P. Percutaneous endoscopic treatment of urothelial tumors of the renal pelvis. Br J Urol 1995;75:736–9.Plancke H.R., Strijbos W.E., Delaere K.P. Percutaneous endoscopic treatment of urothelial tumors of the renal pelvis. Br J Urol 1995;75:736–9.20. Patel A., Soonawalla P., Shepherd S.F. et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol 1996;155:868–74.Patel A., Soonawalla P., Shepherd S.F. et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol 1996;155:868–74.21. Palou J., Piovesan L.F., Huguet J. et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: Recurrence and long-term follow up. J Urol 2004;172:66–9.Palou J., Piovesan L.F., Huguet J. et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: Recurrence and long-term follow up. J Urol 2004;172:66–9.